AI Model Predicting Two-Year Risk of Common Heart Disorder can Easily be Integrated into Healthcare Workflow

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study demonstrates that UNAFIED, a highly accurate artificial intelligence (AI) prediction model which uses machine learning to parse information acquired from a patient's electronic health record (EHR) to predict whether a patient has or might develop detectable AFib within the following two years, can be easily integrated into the healthcare workflow.

UNAFIED is an acronym for Undiagnosed Atrial Fibrillation prediction using Electronic health Data.

Testing implementation and performance in real world conditions, the researchers reported that physicians in a busy medical practice in the Eskenazi Health system in Indianapolis who regularly used the UNAFIED risk prediction model found it easy to use and not time consuming. Most significantly, physicians participating in the study indicated that they believed it helped improve patient care. The non-invasive, inexpensive approach provides a practical option for proactive screening of patients, especially the large number of individuals at elevated risk for AFib.

Individuals at higher risk for AFib include adults living with obesity, many types of heart disease, Type 2 diabetes or sleep apnea, as well those who are smokers or binge alcohol drinkers or have a family history of the disease.

"Unfortunately, atrial fibrillation can be silent until it's disastrous. We developed and validated this risk prediction model to find the instances where atrial fibrillation was silent but still occurring or likely to occur," said Regenstrief Institute Research Scientist Randall Grout, M.D., M.S. "The primary goals of the UNAFIED model are preventing very significant negative medical outcomes and even death.

"Using such indicators as sex, height and weight, prior diagnoses of heart or kidney disease - information already easily available to the clinician - our model performed at the leading edge. It doesn't require extra steps, making it easy for clinicians to integrate into their practice."

Dr. Grout is the first author of the UNAFIED clinical implementation study, a co-author of the national validation study and the first author of the development study. In addition to his Regenstrief appointment, Dr. Grout is a faculty member of the Indiana University School of Medicine and chief health informatics officer at Eskenazi Health.

In the study of clinical implementation, UNAFIED was integrated into the EHR system of a busy cardiology clinic, enabling the algorithm upon which UNAFIED is based to calculate the predicted risk for each patient individually. If the risk factor was found to be above a certain threshold, the model provided visual indicators to the cardiologist that the patient might have an elevated risk of undetected AFib or of developing AFib within the next two years. The workflow also provides recommendations such as performing follow-up heart rhythm and other testing as well as presenting ways to document within the EHR for higher risk or that a patient may actually be experiencing AFib, even if the condition had been previously ruled out. Respectful of professional expertise and experience, the model offers the physician the option of overriding or bypassing the prompts.

According to the Centers for Disease Control and Prevention, there are more than 454,000 hospitalizations with AFib as the primary diagnosis in the U.S. annually. The condition contributes to an estimated 158,000 deaths in the U.S. each year.

Dr. Grout notes that while the algorithm on which UNAFIED is based was built to predict undetected AFib, lessons learned from the development of this model could be employed to develop algorithms for models focused on other conditions as well as specific populations or geographic areas. While some of the predictor variables used may be the same in many or most models - for instance age of patient - others, such as a history of a certain diagnoses, could be customized for the specific disease under scrutiny.

Grout RW, Ateya M, DiRenzo B, Hart S, King C, Rajkumar J, Sporrer S, Torabi A, Walroth TA, Kovacs RJ.
Screening for undiagnosed atrial fibrillation using an electronic health record‒based clinical prediction model: clinical pilot implementation initiative.
BMC Med Inform Decis Mak. 2024 Dec 18;24(1):388. doi: 10.1186/s12911-024-02773-z

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...